About this role
About the role
The Centre for Psychedelic Research (CPR) at Imperial College London is one of the world's leading institutions in psychedelic science — and we are now actively translating that research into NHS clinical services. This is a rare and genuinely pioneering opportunity to sit at the intersection of world-class science and real-world clinical impact, leading the work that will bring ketamine-assisted and psychedelic-assisted psychotherapy into publicly funded mental health care for the first time.
Working through our CIM-KeT programme — a partnership with Central and North West London (CNWL) NHS Foundation Trust — you will be the primary bridge between CPR's research expertise and the NHS systems that must ultimately deliver these therapies at scale.
What you would be doing
In this role, you will lead the translational work of the Centre for Psychedelic Research at a senior level. Your work will span four interconnected areas:
You will identify and establish NHS pilot sites — conducting readiness assessments, co-designing clinical service models with NHS partners, managing regulatory and governance approvals, and overseeing active pilot delivery against agreed milestones You will support the establishment of clinical training infrastructure needed for safe and effective delivery — assisting with designing structured training programmes and competency frameworks for psychiatrists, psychologists, nurses and therapists working with ketamine-assisted and psychedelic-assisted psychotherapy You will be the external face of the CIM-KeT programme — building and sustaining senior relationships with NHS Medical Directors, Directors of Therapies, Integrated Care Board leads, and NHS England stakeholders, and representing CPR at national forums and policy events
What we are looking for
We are looking for an exceptional individual who combines deep specialist knowledge with the interpersonal skills and strategic drive to make things happen in complex systems. You will bring:
Postgraduate-level expertise in a relevant discipline — psychology, psychotherapy, neuroscience, pharmacology, public health, nursing or a related field Demonstrated experience of research translation — taking findings from academic or clinical trial settings into real-world health service contexts Strong working knowledge of the NHS — its structure, commissioning architecture, and how new treatments are introduced into clinical pathways A track record of senior stakeholder engagement — building productive relationships with NHS leadership, commissioners, or equivalent senior audiences Proven project management capability — managing complex, multi-site programmes with multiple partners Knowledge of the regulatory environment for novel therapeutics, including MHRA processes and — ideally — experience with controlled substances
What we can offer you
The opportunity to lead genuinely pioneering work at the cutting edge of mental health science and NHS implementation A position within one of the world's top ten universities, embedded in a world-leading research centre with an international reputation in psychedelic science Close collaboration with a passionate, multidisciplinary team of researchers, clinicians, and NHS partners who are collectively committed to changing mental health treatment
Benefit from a sector-leading salary and remuneration package (including 41 days’ annual leave and generous pension schemes).
Further information
This is a part-time (17.5 hours per week), fixed-term post for 48 months (4 years) .
If you require any further details about the role, please contact: David Erritzoe — ([email protected])